Announcements Trials
Browse Landscape

Status

Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Keratosis, Actinic 3Glioma 3Glioblastoma 2Carcinoma, Basal Cell 2Brain Neoplasms 2Skin Neoplasms 1Pituitary Neoplasms 1Oligodendroglioma 1Neuroectodermal Tumors 1Neoplasms, Neuroepithelial 1Neoplasms, Basal Cell 1Neoplasms 1Neoplasm, Residual 1Neoplasm Metastasis 1Central Nervous System Neoplasms 1Carcinoma, Squamous Cell 1Astrocytoma 1

Interventions

Exercise 19Drug Therapy 18pembrolizumab 13Capecitabine 11Blood Specimen Collection 11Surveys and Questionnaires 10Radiotherapy 10Paclitaxel 9Dexamethasone 9Nivolumab 8Standard of Care 7Oxaliplatin 7Fluorouracil 7Erlotinib Hydrochloride 7apatinib 6Interviews as Topic 6Gemcitabine 6Control Groups 6Cisplatin 6Therapeutics 5Neoadjuvant Therapy 5Mindfulness-Based Cognitive Therapy 5Metformin 5Injections 5Everolimus 5Docetaxel 5Cyclophosphamide 5Bevacizumab 5sintilimab 4atezolizumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Neoplasms × Aminolevulinic Acid × Clear all
NCT05850377 2023-05-09

5-Aminolevulinic Acid (5-ALA) Gliolan®: Usage Increase Proposal for Neurosurgical Procedures in High-Grade Gliomas

Sociedad de Lucha Contra el Cáncer del Ecuador

Unknown
90 enrolled
CNS

Brain Neoplasms, Glioma, Neoplasms, Central Nervous System Neoplasms, Neuroectodermal Tumors, Neoplasms, Neuroepithelial, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon âš¡